| Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study C Fabiani, A Vitale, G Emmi, G Lopalco, L Vannozzi, S Guerriero, ... Clinical rheumatology 36, 191-197, 2017 | 138 | 2017 |
| One year in review 2016: pathogenesis of rheumatoid arthritis E Bellucci, R Terenzi, GM La Paglia, S Gentileschi, A Tripoli, C Tani, ... Clin Exp Rheumatol 34 (5), 793-801, 2016 | 114 | 2016 |
| A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center … A Vitale, A Insalaco, P Sfriso, G Lopalco, G Emmi, M Cattalini, R Manna, ... Frontiers in pharmacology 7, 380, 2016 | 89 | 2016 |
| Surgical therapy of vulvar cancer: how to choose the correct reconstruction? S Gentileschi, M Servillo, G Garganese, S Fragomeni, F De Bonis, ... Journal of Gynecologic Oncology 27 (6), 2016 | 86 | 2016 |
| Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism C Santonocito, R Capizzi, P Concolino, MM Lavieri, A Paradisi, ... British Journal of Dermatology 156 (2), 277-282, 2007 | 76 | 2007 |
| Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study J Sota, A Vitale, A Insalaco, P Sfriso, G Lopalco, G Emmi, M Cattalini, ... Clinical Rheumatology 37, 2233-2240, 2018 | 72 | 2018 |
| Up‐regulation of pro‐inflammatory genes as adaptation to hypoxia in MCF‐7 cells and in human mammary invasive carcinoma microenvironment M Tafani, A Russo, M Di Vito, P Sale, L Pellegrini, L Schito, S Gentileschi, ... Cancer science 101 (4), 1014-1023, 2010 | 71 | 2010 |
| Endometriosis-associated clear cell carcinoma arising in caesarean section scar: a case report and review of the literature G Ferrandina, E Palluzzi, F Fanfani, S Gentileschi, AL Valentini, ... World journal of surgical oncology 14, 1-8, 2016 | 68 | 2016 |
| COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs E Conticini, E Bargagli, M Bardelli, GD Rana, C Baldi, P Cameli, ... Annals of the rheumatic diseases, 2020 | 67 | 2020 |
| Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational … C Fabiani, A Vitale, D Rigante, G Emmi, A Bitossi, G Lopalco, J Sota, ... Clinical rheumatology 38, 407-415, 2019 | 65 | 2019 |
| Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study A Vitale, G Emmi, G Lopalco, S Gentileschi, E Silvestri, C Fabiani, ... Clinical rheumatology 36, 451-455, 2017 | 60 | 2017 |
| The lymphatic superficial circumflex iliac vessels deep branch perforator flap: A new preventive approach to lower limb lymphedema after groin dissection‐preliminary evidence S Gentileschi, M Servillo, G Garganese, S Fragomeni, F De Bonis, A Cina, ... Microsurgery 37 (6), 564-573, 2017 | 59 | 2017 |
| The role of duplex ultrasound in microsurgical reconstruction: review and technical considerations MJ Cho, JG Kwon, CJ Pak, HP Suh, JP Hong Journal of Reconstructive Microsurgery 36 (07), 514-521, 2020 | 58 | 2020 |
| Cumulative retention rate of adalimumab in patients with Behçet’s disease-related uveitis: a four-year follow-up study C Fabiani, J Sota, A Vitale, D Rigante, G Emmi, L Vannozzi, D Bacherini, ... British Journal of Ophthalmology 102 (5), 637-641, 2018 | 54 | 2018 |
| Groin sentinel node biopsy and 18F-FDG PET/CT-supported preoperative lymph node assessment in cN0 patients with vulvar cancer currently unfit for minimally invasive inguinal … G Garganese, A Collarino, SM Fragomeni, V Rufini, G Perotti, ... European Journal of Surgical Oncology 43 (9), 1776-1783, 2017 | 54 | 2017 |
| Skin cancer triage and management during COVID‐19 pandemic L Tagliaferri, A Di Stefani, G Schinzari, B Fionda, E Rossi, L Del Regno, ... Journal of the European Academy of Dermatology and Venereology 34 (6), 1136-1139, 2020 | 50 | 2020 |
| Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: A multicenter retrospective observational study G Lopalco, G Emmi, S Gentileschi, S Guerriero, A Vitale, E Silvestri, ... Modern Rheumatology 27 (6), 1031-1035, 2017 | 50 | 2017 |
| Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease A Vitale, G Emmi, G Lopalco, C Fabiani, S Gentileschi, E Silvestri, ... Clinical rheumatology 36, 2063-2069, 2017 | 49 | 2017 |
| Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid … F Iannone, F Salaffi, M Fornaro, M Di Carlo, S Gentileschi, L Cantarini, ... European journal of clinical investigation 48 (11), e13013, 2018 | 44 | 2018 |
| A prospective evaluation of health-related quality of life following lymphaticovenular anastomosis for upper and lower extremities lymphedema M Salgarello, ML Mangialardi, V Pino, S Gentileschi, G Visconti Journal of Reconstructive Microsurgery 34 (09), 701-707, 2018 | 44 | 2018 |
